Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.
The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time.
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.
Download the white paper to see the full data.
Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.
The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time.
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.
Download the white paper to see the full data.
Pharmacies using EQUIPP Copilot™ closed year-end adherence gaps at 1.5 to 2 times the rate of documentation-only users, proving that point-of-dispensing intelligence is the decisive variable in pharmacy-based adherence outcomes.
The pharmacist access advantage: Patients visit community pharmacies nearly twice as often as primary care physicians, making the dispensing encounter the most consistent clinical touchpoint for chronic disease patients.
Enrollment alone isn't enough: Patient identification alone isn't enough: Knowing which patients are non-adherent creates no clinical value unless pharmacists can act on that insight at the most valuable time.
Cognitive friction is the real barrier: Pharmacist intent is not the problem; workflow interruption required to retrieve adherence and medication related data from a separate system is what drives inconsistent engagement and patient outcomes.
Point-of-dispensing intelligence drives outcomes: When adherence data is surfaced automatically within the existing workflow, pharmacists act on it routinely, producing 15–21 percentage point population-level adherence lifts that are statistically significant at p < 0.000001.
While program enrollment creates the opportunity, point-of-dispensing intelligence determines whether that eligibility translates into measurable patient outcomes.
Download the white paper to see the full data.